Media and Communications Articles
Glaucoma Australia appoints Annie Gibbins next CEO
Glaucoma Australia (GA) is delighted to announce the appointment of Mrs Annie Gibbins as its new Chief Executive Officer (CEO), effective 1 February 2018. She succeeds Mr Geoff Pollard, who will retire after 7 years at the helm of GA.
Increased Optometry Input into Glaucoma Australia Awareness Activities
In a move that further recognises the importance of optometry in managing patients with glaucoma and improving the low glaucoma detection rates in Australia, Glaucoma Australia has made a second optometrist appointment to its Council of Management (Council).
Glaucoma Australia Partnership to Help Over 300,000 Australians
MedAdvisor Limited (ASX: MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce that it has signed a Memorandum of Understanding (MoU) with Glaucoma Australia Inc, to help improve medication adherence in patients living with glaucoma.
New partnership to promote awareness of glaucoma
With the total cost of glaucoma on the Australian economy rising by $120 million per year, two of Australia’s foremost professional associations have established a new partnership to increase awareness of this debilitating eye disease.
Glaucoma Australia supports collaborative care for best patient health outcomes
Glaucoma Australia welcomes the reinstatement of collaborative care arrangements between ophthalmologists and optometrists for patients with glaucoma.
Blue Mountains Save Sight 2014 Charity Concert
A charity performance for Glaucoma Australia featuring The Rat Pack, Cool Classics with a Fresh Twist and Soprano Shu-Cheen Yu an Art Exhibition, silent auction and raffle at Fairmont Resort, 1 Sublime Point Road, Leura.
A new glaucoma initiative: the TARRGET program
In a partnership with Flinders University (SA) and the Lions Eye Institute (WA), Glaucoma Australia are funding the Targeting At Risk Relatives of Glaucoma patients for Early diagnosis and Treatment study (TARRGET), to increase knowledge and awareness of the increased risk of glaucoma to close family members of those known to be affected. The pilot phase of the study is planned to run for one year, with a further one year extension planned.